News

Date
Title
  1. 02/02/2016 Catalent Invests $4.6M To Further Expand Clinical Trials Hub In Singapore

  2. 02/01/2016 Catalent Presents at IPEC-Europe Conference

  3. 01/28/2016 Catalent & Cerenis Therapeutics Announce Phase III Trial of CER-001

  4. 01/26/2016 Catalent Presents "Overcoming Challenges In Formulation Development" at Informex

  5. 01/21/2016 Catalent Announces Appointment of New Development & Analytical Services VP

  6. 01/19/2016 Catalent to Open New Clinical Supply Facility in Japan

  7. 01/14/2016 Evolving to a More Efficient and Lean Clinical Trial Supply Model

  8. 01/13/2016 Catalent Biologics Collaborates with Roche on SMARTag™ Technology

  9. 12/09/2015 Catalent Biologics Announces Appointment of VP, Business Development & Licensing

  10. 12/07/2015 Pfizer Awards Flagship OTC Product Manufacturing Contract To Catalent

  11. 11/26/2015 Catalent Institute Announces Educational Workshop Series

  12. 11/25/2015 Catalent to Discuss Challenges & Logistics of Clinical Trials in Asia

  13. 11/20/2015 Catalent Biologics Expands Analytical And Process Development Capabilities

  14. 11/16/2015 Catalent Working to Re-Start Production at French Facility

  15. 10/27/2015 Catalent Quadruples Cold Chain Capacity in Shanghai

  16. 10/21/2015 Catalent Announces New President of Clinical Supply Services Business

  17. 10/14/2015 Catalent Wins ‘Innovation In Process & Formulation Development’ Award at CPhI

  18. 10/13/2015 Catalent Announces Appointment Of Vice President Of Science And Technology

  19. 10/01/2015 Catalent Launches Optiform® Solution Suite For Accelerated Drug Development

  20. 09/28/2015 Catalent Quality Expert Invited To Discuss Effective Auditing Strategies

  21. 09/24/2015 Demand Led Supply Model To Improve Clinical Trial Supply Chains

  22. 09/10/2015 Patient-Centric Drug Design & Innovative Technologies Symposium

  23. 08/27/2015 Clinical Trial Supply Chain Logistics Discussed At Upcoming Flypharma Conference

  24. 08/05/2015 Catalent Biologics Announces New Advisory Board

  25. 08/03/2015 OptiShell™ Technology for New Chronic Kidney Disease Treatment

  26. 07/28/2015 Catalent, Inc. Appoints J. Martin Carroll to its Board of Directors

  27. 07/23/2015 Applied Drug Delivery Institute Recognizes Innovators with Global Award

  28. 07/22/2015 Catalent Announces Busy Agenda At Controlled Release Society Annual Meeting

  29. 07/07/2015 Catalent Biologics Adds New Technology Platform

  30. 07/02/2015 Catalent Makes Two Key European Appointments In Oral Dose Manufacturing

  31. 06/16/2015 Catalent Expands Packaging Capabilities In Singapore

  32. 05/15/2015 Lipid-Based Solutions to Improve Bioavailability at Drug Delivery Congress

  33. 04/21/2015 Expansion of Glass-Free Injectable Platform with New ADVASEPT™ Lock Technology

  34. 04/20/2015 Catalent Awarded Grant As Part Of Vaccine Research Consortium

  35. 04/15/2015 Catalent Completes Expansion of Complex Oral Solid Manufacturing Facility

  36. 04/14/2015 Catalent To Launch Extension To ADVASEPT™ Technology Range At Interphex

  37. 04/09/2015 Enhanced Solubility and Speed to Market Discussed by Catalent Expert at DDF

  38. 03/30/2015 Catalent Acquires Pharmapak, Australia

  39. 03/20/2015 Catalent to Present Use Of New Technologies At Upcoming Bioassay Conference

  40. 03/16/2015 Catalent Announces New Organization To Speed New Products To Market

  41. 02/26/2015 Catalent Expands Capabilities within European Clinical Supply Services Network

  42. 02/18/2015 Catalent to Present New Data on Benefits of SMARTag™ Technology at World ADC

  43. 02/05/2015 Lipid-Based Solutions Workshop Presented At Drug Delivery & Formulation Summit

  44. 02/02/2015 Catalent to Present Bioavailabity Solutions & Drug Delivery Toolkit at InformEx

  45. 01/28/2015 Catalent Pharma Solutions Further Expands Its High Potency Handling Capability

  46. 01/23/2015 Catalent VP Of Global Operations Wins Program Director Of The Year Award

  47. 01/22/2015 Catalent Expands Coating & Packaging Operations In Eberbach, Germany

  48. 01/19/2015 Catalent Biologics & MGC Pharma Announce Partnership: Biomanufacturing In Asia

  49. 01/14/2015 Catalent & Sanofi To Collaborate On SMARTag™ Antibody-Drug Conjugate Technology

  50. 01/07/2015 Catalent Appoints Two Industry Leaders To Its European Clinical Supply Network

  51. 12/04/2014 Catalent & SELLAS Sign Exclusive Agreement For Therapeutic Reprofiling

  52. 12/02/2014 Catalent and Valerion Collaborate on New Treatments For Orphan Genetic Disorders

  53. 11/13/2014 Catalent Acquires Micron Technologies

  54. 11/03/2014 Catalent Expands Highly Potent And Cytotoxic Clinical Packaging Capabilities

  55. 10/30/2014 Latest Developments in Bioavailability, Drug Delivery & More Presented At AAPS

  56. 10/28/2014 Catalent Appoints Mark Bisset as President, Catalent Asia Pacific

  57. 10/21/2014 ADC Generation Using SMARTag™ Technology Presented At World ADC Congress

  58. 10/14/2014 Catalent Appoints Senior Vice President And General Counsel

  59. 10/08/2014 Catalent and Redwood Bioscience Win Inaugural ‘Innovation In Partnering’ Award

  60. 10/06/2014 Catalent Applied Drug Delivery Institute Collaborates With Lung Cancer Alliance

  61. 10/02/2014 Catalent Acquires Redwood Bioscience Inc. and the SMARTag™ Technology Platform

  62. 09/30/2014 Catalent Announced Full Agenda for 25th Annual CPhI Worldwide Conference

  63. 09/25/2014 Catalent Announces Two Senior Executive Appointments to Its Development Business

  64. 09/24/2014 Catalent and Cingulate Therapeutics Sign Exclusive Agreement

  65. 09/17/2014 New OptiPact™ Technology Introduced By Catalent

  66. 09/15/2014 Best Practices In Risk Mitigation Presented By Catalent At Internal Audit Summit

  67. 09/08/2014 Bioavailability Symposium Announced by Catalent Applied Drug Delivery Institute

  68. 09/04/2014 Catalent Announces Two Senior Appointments To Its Biologics Business

  69. 08/27/2014 Catalent & Minomic Collaborate To Bring New Prostate Cancer Treatment To Market

  70. 08/14/2014 Catalent Confirms Appointment of Two Healthcare Executives to Board of Directors

  71. 07/31/2014 Catalent, Inc. Announces Pricing of Its Initial Public Offering

  72. 07/29/2014 Catalent Expert to Present at Japan Society of Drug Delivery Systems

  73. 07/09/2014 Nine Catalent Experts to Present on Industry Challenges & Drug Delivery at CRS

  74. 07/01/2014 Catalent Marks 40 Years in Japan with New Investments and Country Leader

  75. 06/26/2014 FDA Invites Catalent to Present on New Drug Delivery Technologies

  76. 06/24/2014 New Study: Decreased Mortality & Better Tolerability of ADC w/ SMARTag Platform

  77. 06/19/2014 Latest Developments in ADC Presented by Catalent and Redwood Biosciences at BIO

  78. 06/16/2014 Creating A Culture of Operational Excellence Presented at European Summit

  79. 06/11/2014 Annual Competition Recognizes Talent In Graduate Pharmaceutical Programs

  80. 05/07/2014 Innovation Symposium Announced By Catalent Applied Drug Delivery Institute

  81. 05/02/2014 Oral Drug Delivery Formulation Techniques Showcased At Recent Event

  82. 04/30/2014 Continual Performance Monitoring Of Potency Assays Presented At IBC Conference

  83. 04/03/2014 Catalent Agrees To Biosimilar Collaboration With Zhejiang Hisun Pharma

  84. 04/02/2014 New Drug Delivery Technologies to be Presented by Catalent Experts at ICSE Japan

  85. 03/24/2014 Catalent Increases Stake In Redwood Bioscience

  86. 03/17/2014 Catalent Celebrates 80 Years of Softgel Innovation at Interphex

  87. 03/11/2014 Catalent Launches ADVASEPTTM For Glass-Free Delivery Of Injectable Drugs

  88. 03/10/2014 Use Of QbD To Mitigate Risk In Aseptic Fill/Finish Presented At PDA Conf

  89. 03/06/2014 Catalent Announces Agreement For One Of The First Regenerative Therapies

  90. 02/26/2014 Catalent Announces Two Senior Appointments To Expand Biologics Business

  91. 02/17/2014 Catalent and Redwood Bioscience to Present on Next Generation Drug Conjugates

  92. 02/10/2014 Improved Drug Delivery in Animal Health Presented by Catalent Experts

  93. 02/06/2014 Leading Industry & Academic Experts to Discuss Drug Delivery Technologies

  94. 02/04/2014 Catalent Demonstrates Process Excellence During PEX Week

  95. 01/24/2014 Catalent Files Registration Statement For Initial Public Offering

  96. 01/24/2014 New Technologies and QbD Concepts to be Discussed at Forthcoming Events

  97. 01/23/2014 3rd Annual Global Academic Competition for Life Science Leaders of Tommorrow

  98. 01/07/2014 Catalent and Adamas Pharmaceuticals Enter Into Phase III Manufacturing Agreement

  99. 12/09/2013 Orphan Drug Model to be Debated by Catalent Expert at FDA/CMS Summit

  100. 12/08/2013 Extractables and Leachables for Parenteral and Opthalmic

  101. 12/05/2013 Catalent & Redwood Bioscience present Next Generation Antibody Drug Conjugates

  102. 11/20/2013 Pharmacyclics and Catalent Solidify Partnership on Imbruvica™

  103. 11/19/2013 Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal

  104. 11/11/2013 Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business

  105. 11/06/2013 New Interactive Web Tool Helps Innovators

  106. 11/04/2013 New Drug Delivery Technologies Presented at AAPS

  107. 10/16/2013 Catalent Presents New Technologies at CPhI

  108. 10/14/2013 Compelling New Data on Next Generation Antibody Drug Conjugates

  109. 10/08/2013 Catalent Acquires Relthy to Expand South American Softgel Business

  110. 09/25/2013 Catalent Announces Expansion of Optimelt™ Hot Melt Extrusion

  111. 09/22/2013 Catalent Participates in Inaugural Blackstone Veterans Hiring Summit

  112. 09/19/2013 The Institute Appoints Professor Claus-Michael Lehr to Advisory Board

  113. 09/16/2013 Catalent Pharma Solutions and Supernus Partner for Supply of Trokendi XR™

  114. 09/11/2013 Catalent Experts to Present Collaborative Product Development at EPTM

  115. 09/08/2013 Catalent Appoints First President of Asia Pacific

  116. 09/03/2013 Catalent Applied Drug Delivery Institute Announces European Educational Event

  117. 07/28/2013 Catalent Completes Acquisition of Majority Share in Chinese Softgel Business

  118. 07/15/2013 Advances in Modified & Controlled Release - Catalent at 40th Annual CRS Meeting

  119. 07/09/2013 Catalent and Biota Pharmaceuticals Expand Their Alliance

  120. 07/07/2013 Catalent Creates New Advanced Delivery Technologies Business Unit

  121. 06/19/2013 Catalent Officially Launches New Capabilities at CPhI China

  122. 06/11/2013 Catalent Breaks Ground of its Winchester, KY CR Manufacturing Facility

  123. 05/15/2013 Worldwide Competition Recognizes Next-Generation Scientific Talent

  124. 05/12/2013 Catalent Wins Two Prestigious Process Excellence Awards

  125. 05/09/2013 Omega-3 Trends and Innovations at Vitafoods

  126. 04/24/2013 Catalent Announces Opening of New Single-Use Biomanufacturing Center

  127. 04/22/2013 Company Receives Two PEX Network European Awards Nominations

  128. 04/18/2013 Catalent Experts Exhibit and Present at BIO and Interphex 2013

  129. 04/15/2013 Catalent Announces Two Senior Appointments to Drive Growth in China

  130. 04/09/2013 Catalent Biologics Expands Into ADCs Through Exclusive License

  131. 03/25/2013 catalent leader to chair discussions on optimizing clinical operation in china

  132. 03/19/2013 Catalent Australia and Medipharm Partner to Supply Malaysian Market

  133. 03/18/2013 Experts Consider Challenging Tech Transfers at Dusseldorf Pharma Congress

  134. 03/10/2013 Catalent Announces Major China Expansion with Two New Facilities

  135. 03/06/2013 Applied Drug Delivery Institute Welcomes Accomplished Life Sciences Leader

  136. 03/04/2013 Catalent Quality Development Leader to Present at China Clinical Trials

  137. 02/25/2013 Speeding Drug Development Through Use of High Yield Stable GPEx® Technology

  138. 02/24/2013 Catalent Presents Drug Delivery Strategies at Improving Solubility in Philly

  139. 01/29/2013 Catalent Applied Drug Delivery Institute Holds 2nd Global Academic Competition

  140. 01/28/2013 The Impact of Emerging Bioassay Technologies Presented at WCBP Conference

  141. 01/22/2013 Presenting Better Treatments Through Bioavailability Enhancement

  142. 01/21/2013 Accelerating Development from CDNA Sequence to Master Cell Bank Candidate

  143. 01/09/2013 Catalent Makes Investment to Expand Inhalation Capabilities in RTP, NC

  144. 01/07/2013 Catalent and Aegerion Partner on Launch of Newly FDA Approved Juxtapid™

  145. 12/12/2012 Catalent and UMN Pharma announce collaboration for production in Japan

  146. 12/12/2012 Bio-Process Systems Alliance Elects New Director from Catalent

  147. 12/06/2012 Catalent to supply the newly approved Exelixis COMETRIQ™

  148. 11/27/2012 Oral Drug Delivery for Macromolecules Using Softgel Lipid Delivery System

  149. 11/25/2012 Faster Pipeline Progression Discussed by Catalent Expert EAC 2012

  150. 11/19/2012 Catalent Experts to Speak at Pharma Integrates 2012

  151. 11/12/2012 Catalent Announces Cell Line Sales Agreement with CEVEC Pharmaceuticals

  152. 11/08/2012 Extractable and Leachables for Biological and High Risk Dosage Forms

  153. 10/16/2012 Catalent Wins Fifth Consecutive European Outsourcing Award

  154. 10/15/2012 Catalent Announces Launch of Catalent Applied Drug Delivery Institute

  155. 10/09/2012 Catalent Licenses Technology with NJIT

  156. 10/07/2012 Catalent Present at the 2012 AAPS Annual Meeting

  157. 10/01/2012 Catalent Announces Global Alliance with PAREXEL

  158. 09/30/2012 Catalent Enters Into Commerical Supply Agreement with Vivus

  159. 09/19/2012 Catalent Expert Invited to Speak on Advanced Delivery Technologies

  160. 09/17/2012 Optimizing Clinical Supply Processes and Maximizing Budgets Presented

  161. 09/17/2012 Catalent Completes $350 Million 7.875% Senior Notes Offering

  162. 09/12/2012 Catalent and CTC Partner to Help Korean Pharma

  163. 09/05/2012 Catalent Quality Expert Presents At 2012 ICH Q10 Workshop

  164. 07/23/2012 Catalent Announces Commencement of Supply of Abilify®

  165. 07/18/2012 Expert Invited to Speak on the Advantages of Single Use Biomanufacturing

  166. 07/17/2012 Catalent Expert Will Present at PERI

  167. 07/10/2012 Catalent Expert Presents at 2012 CRS Conference

  168. 06/21/2012 Catalent Experts Present at CPhI/ICSE China 2012

  169. 06/20/2012 Catalent and Bend Provide Solutions for Controlled-Release Technologies

  170. 06/19/2012 Frazier Healthcare Acquires Packaging Operations from Catalent Pharma Solutions

  171. 06/10/2012 Catalent Expert Conducts Workshop On Solid Dosage Forms

  172. 06/04/2012 Catalent Increases Sterile Fill-Finish Manufacturing Capacity

  173. 05/29/2012 Catalent Enters Agreement to Sell Its U.S. Commercial Packaging Operations

  174. 05/15/2012 Catalent Announces Winners of Global Academic Competion

  175. 05/13/2012 Drug Delivery/Formulation Issues Identified As Concerns In Technology Survey

  176. 05/10/2012 Catalent Expert Gives Working Group Update At Conference

  177. 04/29/2012 Biosimilars Webinar Presented by Catalent Expert

  178. 04/26/2012 Case Study Presented on Achieving Biological Assay Success

  179. 04/16/2012 Catalent Expert Presents at German Pharma Congress

  180. 04/15/2012 Nascent and Catalent Sign Cancer Antibody Development Deal

  181. 04/11/2012 Two Global Catalent Experts Present at AAPS Workshop

  182. 04/10/2012 Catalent Expert To Share Formulation Development Expertise at Aerosol School

  183. 04/09/2012 Catalent Expert to Present at ISPE Japan 2012

  184. 04/03/2012 BASF and Catalent Join Forces to Solve Bioavailability Challenges

  185. 04/02/2012 Catalent Expert Presents Case Study at PDA

  186. 03/29/2012 Pharma Industry in NJ: A Panel Discussion

  187. 03/21/2012 Catalent Extends Development and Analytical Solutions Capabilities in UK

  188. 03/14/2012 Catalent Experts To Present Drug Delivery Technologies At ICSE/CPhI Japan 2012

  189. 03/11/2012 Catalent Appoints a Vice President of Commercial Excellence

  190. 03/07/2012 Expert Presents At The 5th Annual Comparator Studies Conference

  191. 03/06/2012 Catalent Continues Investment In Global Clinical Supply Services

  192. 03/01/2012 Drug Delivery Innovations Presented at 2nd Lyophilization Americas Conference

  193. 02/28/2012 Catalent Acquires 100% of R.P. Scherer - Eberbach, Germany

  194. 02/20/2012 Catalent Expert Presents on Protein Expression in CHO Cells

  195. 02/19/2012 Catalent Expert Presents Effective Global Supply Chain Solutions

  196. 02/16/2012 Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit

  197. 02/15/2012 Catalent and NewMarket Pharmaceuticals to Develop Better Treatments

  198. 01/31/2012 Expansion Advanced Dose Form Facility In Italy Complete

  199. 01/29/2012 Catalent Acquires Current Minority Interest in R.P. Scherer, Eberbach, Germany

  200. 01/24/2012 Catalent Expands Controlled Release Drug Development & Supply

  201. 01/18/2012 Catalent Expert To Present On Virological Safety

  202. 01/17/2012 Catalent Expert To Present On Technology Delivery

  203. 01/15/2012 Catalent Expert to Present Strategies for Improved Oral Delivery

  204. 01/03/2012 Catalent Expert to Present at Peptalk 2012

  205. 12/06/2011 Catalent Plans to Increase Biologic Development and Manufacturing Capabilities

  206. 11/30/2011 Catalent Expert to Present Strategies to Support Intelligent Global Sourcing

  207. 11/08/2011 New Vice President and General Manager of Sterile Technologies Appointed

  208. 11/02/2011 Catalent Expert To Discuss The Effect of Immunoglobulin

  209. 11/01/2011 Catalent Joins Inhalation Experts to Advance Industry Science

  210. 10/19/2011 Catalent Focus On Expansion and New Technologies at ICSE/CPhI

  211. 10/16/2011 Catalent Highlight New Drug Delivery Technologies and Scientific Expert Events

  212. 10/05/2011 Catalent Expands Analytical Services Capabilities With A New Lab in Swindon, UK

  213. 09/27/2011 Catalent Expert to Present A Case Study of A Phase III Trial

  214. 09/26/2011 Expert to Present Technology Solutions for Biologics Challenges

  215. 09/25/2011 Catalent Expert Presents On Practical Considerations for Bioassays

  216. 09/22/2011 Catalent to Present Webinar on Applied Drug Delivery

  217. 09/20/2011 New VP Business Development, Zydis® Technology, Appointed

  218. 09/20/2011 Catalent and Toyobo Team Up To Launch GPEx®

  219. 09/19/2011 Catalent Announces Partnership With Toyobo Biologics, Inc.

  220. 09/13/2011 Catalent Expansions Show Close Pharma-Biz Tracking

  221. 09/12/2011 Catalent Announces Expansion of Its Advanced Dose Form Facility in Italy

  222. 09/11/2011 Expert to Present at 4th Annual Drug Repositioning Conference

  223. 09/07/2011 Catalent Expert Presents On Viral Safety

  224. 08/21/2011 Catalent to Acquire Aptuit LLC's Clinical Trial Supplies Business

  225. 08/14/2011 Catalent Expert Elsevier Webinar on Biosimiliars and Biobetters

  226. 08/07/2011 Catalent Expert Presents at 3rd Annual FDA Supplier Quality Management Congress

  227. 08/02/2011 Catalent Announces Cold-Chain Expansions to Meet Increasing Customer Demand

  228. 07/27/2011 Catalent Expert Presents New Technologies at 38th Annual CRS Conference

  229. 07/13/2011 Novel OSDrC® Optimized Dosing Technology Introduced

  230. 07/04/2011 Catalent Expert To Present Webinar On Biosimilars and Biobetters

  231. 06/29/2011 Catalent Invests In Global Clinical Suppy Services Capacity and Offering

  232. 06/28/2011 New Medication Delivery Solutions President Appointed

  233. 06/22/2011 Catalent Experts Present at HBA Global Expo 2011

  234. 06/22/2011 Catalent Presents At 7th Annual Improving Solubility Summit

  235. 06/15/2011 CEVEC and Catalent Offer Joint Cell Line Development Service

  236. 06/10/2011 Drug Delivery Trends and Topics With Catalent VP of Strategy

  237. 05/16/2011 Catalent’s Patient Adherence Packaging Design Honored

  238. 05/08/2011 Catalent Expert Presents the Requirements and Importance of Viral Safety

  239. 05/03/2011 New Vice President of Scientific Affairs Appointed

  240. 05/01/2011 Study Shows Adherence Packaging Solutions Drives Gains in Patient Persistency

  241. 04/13/2011 Catalent Announces New Sales Leadership Appoinments

  242. 03/22/2011 Catalent Presents at the 5th Annual Improving Solubility Conference

  243. 03/20/2011 Catalent to Present at INTERPHEX 2011

  244. 03/17/2011 Catalent Appoints New Vice President/General Manager of Consumer Health Softgel

  245. 03/13/2011 Catalent Pharma Solutions Appoints New Senior Vice President of Human Resources

  246. 03/09/2011 Catalent's Schorndorf Facility Celebrates 50 Years

  247. 03/08/2011 Catalent Expert to Teach Drug Development at Institute

  248. 03/08/2011 Catalent Expert Speaks on the Future of Biologics

  249. 02/27/2011 Catalent agrees to sell Printed Components business

  250. 02/16/2011 Catalent Experts Featured At PQRI Workshop

  251. 02/14/2011 Catalent Acquires Exclusive Rights to Lyopan® Fast-Dissolve Technology

  252. 02/02/2011 Catalent to present Efficient Solid-State Screening Using FT-Raman Spectroscopy

  253. 01/30/2011 Catalent Announces Partnership with Nuron Biotech for Phase III Clinical Study

  254. 01/23/2011 Catalent Expert to Present Drug Delivery Solutions to Enhance Bioavailability

  255. 01/18/2011 Catalent Experts to Present Webinar on Fit-For-Purpose Strategies for Solid-Form

  256. 01/16/2011 Catalent Clinical Supply Services Enhances Direct Global Comparator Sourcing...

  257. 01/13/2011 Catalent Expert Delivers US Pharmacopeia Update at 10th Annual Europe Conference

  258. 01/09/2011 Catalent Appoints New Leadership Talent in Global Manufacturing Sites

  259. 01/04/2011 Catalent Clinical Supply Continues to Invest in Automation to Drive High ...

  260. 12/20/2010 Microbiology and Sterility in Pharmaceuticals and Medical Devices

  261. 12/09/2010 Lean Pharma Product Development

  262. 12/08/2010 Catalent Strengthens and Expands

  263. 12/07/2010 Catalent Scientists to Chair

  264. 12/01/2010 Catalent Vice President Shares

  265. 11/10/2010 Catalent Expert to Present

  266. 11/03/2010 Catalent Provides a Simplified

  267. 11/01/2010 Nine Catalent Experts to Present

  268. 10/27/2010 Senior Director of Biotechnology

  269. 10/26/2010 Catalent Appoints New Global

  270. 10/25/2010 Catalent Receives Award

  271. 10/12/2010 Catalent's Eberbach, Germany Site

  272. 10/10/2010 Catalent Expert Leads Workshop

  273. 10/03/2010 Catalent R&D Director Appointed

  274. 09/13/2010 Catalent to Present Ground-Breaking

  275. 09/08/2010 Catalent Softgel Expert to Present

  276. 08/23/2010 Catalent Provides Sunesis

  277. 08/23/2010 Catalent Pharma Solutions Provides Manufacturing and Packaging Expertise

  278. 08/08/2010 World-Class Optiform™ Compound

  279. 07/25/2010 Catalent Scientists to Present

  280. 07/22/2010 Catalent Principal Scientists

  281. 07/20/2010 Catalent Pharma Solutions Adds Pharma

  282. 07/14/2010 Catalent Expert Appointed as Chair

  283. 06/27/2010 Catalent Expert Appointed

  284. 06/27/2010 Catalent Director of Research

  285. 06/21/2010 TraceLink and Catalent Deliver

  286. 06/15/2010 Catalent Joins Business Ethics

  287. 06/13/2010 Senior Director of Biotechnology

  288. 06/10/2010 Catalent Pharma Solutions

  289. 06/09/2010 Catalent Expert Presenting

  290. 06/09/2010 Catalent to Exhibit

  291. 05/10/2010 Catalent Scientists to Present

  292. 05/10/2010 Catalent Announces Lead

  293. 05/09/2010 Catalent Appoints New Vice President

  294. 05/02/2010 Catalent Pharma Solutions

  295. 03/24/2010 Catalent Formulation Expert

  296. 03/22/2010 Catalent Appoints Two

  297. 03/10/2010 Catalent to Present Webinar

  298. 02/17/2010 Catalent Scientist to Co-Chair

  299. 02/10/2010 Catalent Scientist to Present at 2010

  300. 02/01/2010 Catalent Pharma Solutions Appoints

  301. 01/31/2010 Catalent Adds Potent Drug

  302. 01/13/2010 Catalent Expands Packaging Capacity

  303. 01/10/2010 Catalent Solidifies Inhalation

  304. 11/23/2009 Catalent Appoints New Vice President of Global Sales

  305. 11/15/2009 Catalent's Printed Components Plant in Dublin is the First Secondary

  306. 11/04/2009 Catalent Pharma Solutions Enters a Strategic Alliance with Endotis Pharma

  307. 11/03/2009 Catalent Expands Capabilities in Testing for Melamine in Food

  308. 11/02/2009 FDA Approves New Salix Product Exclusively in Catalent's Zydis®

  309. 11/02/2009 Catalent to Present at American Association of Pharmaceutical Scientists Meeting

  310. 10/22/2009 Catalent Develops New Decorin Molecule Form, Strikes Deal With Euclid

  311. 10/19/2009 Catalent Wins Outsourcing Award

  312. 10/18/2009 Catalent Offers the Anti-Counterfeiting DigiTrack™ Digital Watermarking System

  313. 10/06/2009 Catalent Pharma Solutions German Facility Successfully Completes FDA Audit

  314. 10/05/2009 Catalent Pharma Solutions' United Kingdom Packaging Site Receives High

  315. 09/27/2009 Catalent Pharma Solutions Appoints New Sterile Segment President

  316. 09/23/2009 Catalent and GlaxoSmithKline Extend Contractual Agreement

  317. 08/30/2009 Catalent's New Digital Offset Press Reduces Lead Times for Printed Components

  318. 08/19/2009 Catalent Pharma Solutions Creates New Development & Clinical Services Segment

  319. 08/18/2009 Catalent Pharma Solutions Buenos Aires Facility Successfully Completes First FDA Audit

  320. 08/12/2009 Catalent Receives "Preferred Partner Award in Technology" from Wyeth

  321. 06/24/2009 Catalent Pharma Solutions Appoints New Senior Vice President

  322. 05/31/2009 Catalent Pharma Solutions Appoints New Senior Vice President

  323. 05/04/2009 Catalent Pharma Solutions Supports Global Industry Response

  324. 04/30/2009 Catalent Brings Innovative Printing Technology

  325. 04/08/2009 Catalent Pharma Solutions Celebrates 75 Years of Softgel Innovation in 2009

  326. 03/30/2009 BAVARIA Industriekapital AG Announces Acquisition of Osny

  327. 03/17/2009 Catalent Pharma Solutions Announces Printed Components

  328. 03/04/2009 Catalent Pharma Solutions Appoints New President and Chief Executive Officer